ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Similar documents
ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

PPHP 2017 Formulary 2017 Step Therapy Criteria

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

**CRITERIA UNDER CMS REVIEW**

HEALTHTEAM ADVANTAGE PLAN 2017 Step Therapy Criteria Pending CMS Approval

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Step Therapy Group. Atypical Antipsychotic Agents

U T I L I Z A T I O N E D I T S

Step Therapy Medications

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Texas Prior Authorization Program Clinical Edit Criteria

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

ALPHA GLUCOSIDASE INHIBITOR THERAPY

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

Pharmacy Formulary Updates for January 2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

ADHD STIMULANTS-S(SHC)

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Step Therapy Requirements. Effective: 03/01/2015

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTICONVULSANTS. Details

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Step Therapy Criteria 2019

Step Therapy Requirements

Medications and Children Disorders

Step Therapy Requirements. Effective: 1/1/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Step Therapy Criteria

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ACYCLOVIR OINT (CCHP2017)

Step Therapy Requirements. Effective: 11/01/2018

2016 Step Therapy (ST) Criteria

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Step Therapy Criteria

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

ALLERGIC CONJUNCTIVITIS AGENTS

Step Therapy Requirements. Effective: 05/01/2018

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

2017 Step Therapy Criteria

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

2017 PRIOR AUTHORIZATION CRITERIA TABLE OF CONTENTS

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

WELLCARE/ OHANA HEALTH PLAN

Quarterly pharmacy formulary change notice

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

Opioid Management Program October 2018

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

Antipsychotic Medications Age and Step Therapy

Quarterly pharmacy formulary change notice

Blue Medicare HMO Essential 2015 Quantity Limit List Blue Medicare Rx Standard 2015 Quantity Limit List

2018 PRIOR AUTHORIZATION CRITERIA TABLE OF CONTENTS

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

Otezla. Otezla (apremilast) Description

2018 PRIOR AUTHORIZATION CRITERIA TABLE OF CONTENTS

OXYCODONE IR (oxycodone)

Opioid Management Program May 2018

NorthSTAR. Pharmacy Manual

Transcription:

ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 20 MG FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 40 MG FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 80 MG Step Therapy 2017 Last Updated: 5/23/2017 FETZIMA TITRATION CAPSULE ER 24 HOUR THERAPY PACK 20 & 40 MG MARPLAN TABLET 10 MG PAXIL SUSPENSION 10 MG/5ML PEXEVA TABLET 10 MG PEXEVA TABLET 20 MG PEXEVA TABLET 30 MG PEXEVA TABLET 40 MG TRINTELLIX TABLET 10 MG TRINTELLIX TABLET 20 MG TRINTELLIX TABLET 5 MG Claim will pay automatically for MARPLAN, EMSAM, TRINTELLIX, PAXIL, PEXEVA, FETZIMA, or FETZIMA TITRATION PACK if enrollee has a paid claim for at least a 1 days supply of MIRTAZAPINE, MIRTAZAPINE ODT, PHENELZINE SULFATE, TRAZODONE HCL, CITALOPRAM HYDROBROMIDE, ESCITALOPRAM OXALATE, FLUOXETINE HCL, FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE ER, PAROXETINE HCL, PAROXETINE HCL ER, SERTRALINE HCL, DULOXETINE HCL, VENLAFAXINE HCL, VENLAFAXINE HCL ER, AMITRIPTYLINE HCL, AMOXAPINE, DOXEPIN HCL, IMIPRAMINE HCL, NORTRIPTYLINE HCL, PROTRIPTYLINE HCL, BUPROPION HCL, or BUPROPION HCL SR in the past 365 days. Otherwise, Step 2 medications require a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Antidepressant, OR (2) history of adverse event with Step 1 Antidepressant, OR (3)Step 1 Antidepressant is contraindicated. 1

ARISTADA ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882 MG/3.2ML INTRAMUSCULAR Claim will pay automatically for ARISTADA if enrollee has a paid claim for at least a 1 days supply of ABILIFY MAINTENA or LATUDA in the past 365 days. Otherwise, ARISTADA requires a step therapy exception request indicating: (1) history of inadequate treatment response with ABILIFY MAINTENA or LATUDA, OR (2) history of adverse event with ABILIFY MAINTENA or LATUDA, OR (3) ABILIFY MAINTENA and LATUDA are contraindicated. 2

ATOPIC DERMATITIS ELIDEL CREAM 1 % EXTERNAL tacrolimus ointment 0.03 % external tacrolimus ointment 0.1 % external Patient needs to have a paid claim for at least TWO formulary topical corticosteroids 3

ATYPICALS ABILIFY MAINTENA SUSPENSION RECONSTITUTED 300 MG INTRAMUSCULAR ABILIFY MAINTENA SUSPENSION RECONSTITUTED 300 MG INTRAMUSCULAR (1.5ML SYRINGE) ABILIFY MAINTENA SUSPENSION RECONSTITUTED 400 MG INTRAMUSCULAR clozapine tablet dispersible 100 mg oral clozapine tablet dispersible 150 mg oral clozapine tablet dispersible 200 mg oral clozapine tablet dispersible 25 mg oral FANAPT TABLET 1 MG FANAPT TABLET 10 MG FANAPT TABLET 12 MG FANAPT TABLET 2 MG FANAPT TABLET 4 MG FANAPT TABLET 6 MG FANAPT TABLET 8 MG FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG GEODON SOLUTION RECONSTITUTED 20 MG INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 156 MG/ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INTRAMUSCULAR paliperidone er tablet extended release 24 hour 1.5 mg oral paliperidone er tablet extended release 24 hour 3 mg oral paliperidone er tablet extended release 24 hour 6 mg oral paliperidone er tablet extended release 24 hour 9 mg oral RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG INTRAMUSCULAR SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL VERSACLOZ SUSPENSION 50 MG/ML VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG Claim will pay automatically for FANAPT, FANAPT TITRATION PACK, PALIPERIDONE, INVEGA SUSTENNA, RISPERDAL CONSTA, VERSACLOZ, CLOZAPINE ODT, SAPHRIS, ABILIFY MAINTENA, or GEODON if enrollee has a paid claim for at least a 1 4

days supply of a Latuda in the past 365 days. Otherwise, Step 2 Antipsychotics require a step therapy exception request indicating any ONE of the following: (1) diagnosis that is not covered by Latuda (i.e. Acute treatment of agitation for Abilify injection or Geodon injection) OR (2) history of inadequate treatment response with Latuda, OR (3) history of adverse event with Latuda, OR (4)Latuda is contraindicated. 5

AUBIGIO AUBAGIO TABLET 14 MG AUBAGIO TABLET 7 MG CLAIM WILL PAY AUTOMATICALLY FOR Aubagio IF ENROLLEE HAS A PAID CLAIM FOR AT LEAST A 1 DAYS SUPPLY OF Gilenya or Tecfidera IN THE PAST 365 DAYS. OTHERWISE, Aubagio REQUIRES A STEP THERAPY EXCEPTION REQUEST INDICATING: (1) HISTORY OF INADEQUATE TREATMENT RESPONSE WITH Gilenya or Tecfidera, OR (2) HISTORY OF ADVERSE EVENT WITH Gilenya or Tecfidera, OR (3) Gilenya or Tecfidera IS CONTRAINDICATED. 6

FENTANYL fentanyl patch 72 hour 100 mcg/hr transdermal fentanyl patch 72 hour 12 mcg/hr transdermal fentanyl patch 72 hour 25 mcg/hr transdermal fentanyl patch 72 hour 50 mcg/hr transdermal fentanyl patch 72 hour 75 mcg/hr transdermal Claim will pay automatically for Fentanyl patches if enrollee has paid claims history of Any 1 days supply in the past 365 days of Morphine ER tablets (MS Contin generic only), Methadone, or Oxycodone ER. Otherwise, the drug requires a step therapy exception request indicating any ONE of the following: (1) history of inadequate treatment response to Morphine ER tablets (MS Contin generic only), Methadone, or Oxycodone ER OR (2) history of adverse event with Morphine ER tablets (MS Contin generic only), Methadone, or Oxycodone ER OR (3) Morphine ER, Methadone, or Oxycodone ER are contraindicated. 7

IMMUNOMODULATORS ACTEMRA SOLUTION 200 MG/10ML INTRAVENOUS ACTEMRA SOLUTION 400 MG/20ML INTRAVENOUS ACTEMRA SOLUTION 80 MG/4ML INTRAVENOUS ACTEMRA SOLUTION PREFILLED SYRINGE 162 MG/0.9ML CIMZIA KIT 2 X 200 MG CIMZIA PREFILLED KIT 2 X 200 MG/ML COSENTYX SENSOREADY PEN SOLUTION AUTO-INJECTOR 150 MG/ML COSENTYX SOLUTION PREFILLED SYRINGE 150 MG/ML KINERET SOLUTION PREFILLED SYRINGE 100 MG/0.67ML ORENCIA CLICKJECT SOLUTION AUTO-INJECTOR 125 MG/ML ORENCIA SOLUTION PREFILLED SYRINGE 125 MG/ML ORENCIA SOLUTION RECONSTITUTED 250 MG INTRAVENOUS SIMPONI ARIA SOLUTION 50 MG/4ML INTRAVENOUS SIMPONI SOLUTION AUTO- INJECTOR 100 MG/ML SIMPONI SOLUTION AUTO- INJECTOR 50 MG/0.5ML SIMPONI SOLUTION PREFILLED SYRINGE 100 MG/ML SIMPONI SOLUTION PREFILLED SYRINGE 50 MG/0.5ML STELARA SOLUTION PREFILLED SYRINGE 45 MG/0.5ML STELARA SOLUTION PREFILLED SYRINGE 90 MG/ML XELJANZ TABLET 5 MG Patient needs to have a paid claim for one Step 1 drug (Enbrel, Humira, or Cyclosporine) prior to filling a Step 2 drug (Actemra, Cimzia, Cosentyx, Kineret, Orencia, Stelara, Simponi, or Xeljanz ). For diagnosis of cryopyrin-associated periodic syndromes, Kineret will be approved. 8

IMMUNOSUPPRESSANTS ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 0.5 MG ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 1 MG ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 5 MG AZASAN TABLET 100 MG AZASAN TABLET 75 MG NULOJIX SOLUTION RECONSTITUTED 250 MG INTRAVENOUS ZORTRESS TABLET 0.25 MG ZORTRESS TABLET 0.5 MG ZORTRESS TABLET 0.75 MG Claim will pay automatically for Non-Preferred Brand Immunosuppressants (i.e. Astagraf, Azasan, Nulojix, or Zortress) if enrollee has a paid claim for at least a 1 days supply of a CYCLOSPORINE, CYCLOSPORINE MODIFIED, GENGRAF, MYCOPHENOLATE MOFETIL, MYCOPHENOLIC ACID DR, TACROLIMUS, or AZATHIOPRINE in the past 365 days. Otherwise, Non-Preferred Brand Immunosuppressants require a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Immunosuppressants, OR (2) history of adverse event with Step 1 Immunosuppressants, OR (3)Step 1 Immunosuppressants is contraindicated. 9

MS THERAPY AMPYRA TABLET EXTENDED RELEASE 12 HOUR 10 MG Claim will pay automatically for Ampyra if enrollee has a paid claim for at least a 1 days supply of Copaxone, Betaseron, Gilenya, or Tecfidera in the past 365 days. Otherwise, Ampyra requires a step therapy exception request indicating: (1) history of inadequate treatment response with Copaxone, Betaseron, Gilenya, or Tecfidera OR (2) history of adverse event with Copaxone, Betaseron, Gilenya, or Tecfidera OR (3) Copaxone, Betaseron, Gilenya, and Tecfidera are contraindicated. 10

OPSUMIT OPSUMIT TABLET 10 MG Claim will pay automatically for Opsumit if enrollee has a paid claim for at least a 1 days supply of Letairis or Tracleer in the past 365 days. Otherwise, Opsumit requires a step therapy exception request indicating: (1) history of inadequate treatment response with Letairis or Tracleer OR (2) history of adverse event with Letairis or Tracleer OR (3) Letairis or Tracleer is contraindicated. 11

OXYCODONE ER OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 10 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 15 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 20 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 30 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 40 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 60 MG OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 80 MG Patient needs to have a paid claim for at least a 1 day supply of any TWO Step 1 drugs (APAP/codeine, Endocet, hydrocodone/apap, Lorcet, oxycodone/apap, oxycodone/asa, oxycodone/ibuprofen, Vicodin, Vicodin HP, Ascomp/cod, Lortab ) prior to filling a oxycodone ER. 12

PROLIA PROLIA SOLUTION 60 MG/ML Patient needs to have a paid claim for one Step 1 drug ( alendronate, ibandronate, pamidronate, zolendronic acid, or Zometa ) prior to filling a Prolia. For osteoporosis prophylaxis in men at high risk for bone fractures after receiving androgen deprivation therapy for nonmetastatic prostate cancer and in women at high risk for bone fractures after receiving adjuvant aromatase inhibitor therapy for breast cancer, Prolia will be approved. 13

RELISTOR RELISTOR SOLUTION 12 MG/0.6ML RELISTOR SOLUTION 12 MG/0.6ML (0.6ML SYRINGE) RELISTOR SOLUTION 8 MG/0.4ML RELISTOR TABLET 150 MG Claim will pay automatically for Relistor if enrollee has a paid claim for at least a 1 days supply of Amitiza in the past 365 days. Otherwise, Relistor requires a step therapy exception request indicating: (1) history of inadequate treatment response with Amitiza, OR (2) history of adverse event with Amitiza, OR (3) Amitiza is contraindicated. 14

UCERIS UCERIS FOAM 2 MG/ACT RECTAL UCERIS TABLET EXTENDED RELEASE 24 HOUR 9 MG Claim will pay automatically for Uceris if enrollee has a paid claim for at least a 1 days supply of any formulary corticosteroid used to treat ulcerative colitis in the past 365 days. Otherwise, Uceris requires a step therapy exception request indicating: (1) history of inadequate treatment response with formulary corticosteroid used to treat ulcerative colitis, OR (2) history of adverse event with formulary corticosteroid used to treat ulcerative colitis, OR (3) formulary corticosteroid used to treat ulcerative colitis is contraindicated. 15

XTANDI XTANDI CAPSULE 40 MG Claim will pay automatically for Xtandi if enrollee has a paid claim for at least a 1 days supply of Zytiga in the past 365 days. Otherwise, Xtandi requires a step therapy exception request indicating: (1) history of inadequate treatment response with Zytiga OR (2) history of adverse event with Zytiga OR (3) Zytiga is contraindicated. 16

Alphabetical Listing A ABILIFY MAINTENA SUSPENSION RECONSTITUTED 300 MG INTRAMUSCULAR... 4 ABILIFY MAINTENA SUSPENSION RECONSTITUTED 300 MG INTRAMUSCULAR (1.5ML SYRINGE)... 4 ABILIFY MAINTENA SUSPENSION RECONSTITUTED 400 MG INTRAMUSCULAR... 4 ACTEMRA SOLUTION 200 MG/10ML INTRAVENOUS... 8 ACTEMRA SOLUTION 400 MG/20ML INTRAVENOUS... 8 ACTEMRA SOLUTION 80 MG/4ML INTRAVENOUS... 8 ACTEMRA SOLUTION PREFILLED SYRINGE 162 MG/0.9ML... 8 AMPYRA TABLET EXTENDED RELEASE 12 HOUR 10 MG... 10 ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR... 2 ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR... 2 ARISTADA PREFILLED SYRINGE 882 MG/3.2ML INTRAMUSCULAR... 2 ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 0.5 MG... 9 ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 1 MG... 9 ASTAGRAF XL CAPSULE EXTENDED RELEASE 24 HOUR 5 MG... 9 AUBAGIO TABLET 14 MG... 6 AUBAGIO TABLET 7 MG... 6 AZASAN TABLET 100 MG... 9 AZASAN TABLET 75 MG... 9 C CIMZIA KIT 2 X 200 MG... 8 CIMZIA PREFILLED KIT 2 X 200 MG/ML... 8 clozapine tablet dispersible 100 mg oral... 4 clozapine tablet dispersible 150 mg oral... 4 clozapine tablet dispersible 200 mg oral... 4 clozapine tablet dispersible 25 mg oral... 4 COSENTYX SENSOREADY PEN SOLUTION AUTO-INJECTOR 150 MG/ML... 8 COSENTYX SOLUTION PREFILLED SYRINGE 150 MG/ML... 8 E ELIDEL CREAM 1 % EXTERNAL... 3 EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL... 1 EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL... 1 EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL... 1 F FANAPT TABLET 1 MG... 4 FANAPT TABLET 10 MG... 4 FANAPT TABLET 12 MG... 4 FANAPT TABLET 2 MG... 4 FANAPT TABLET 4 MG... 4 FANAPT TABLET 6 MG... 4 FANAPT TABLET 8 MG... 4 FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG... 4 fentanyl patch 72 hour 100 mcg/hr transdermal... 7 fentanyl patch 72 hour 12 mcg/hr transdermal... 7 fentanyl patch 72 hour 25 mcg/hr transdermal... 7 fentanyl patch 72 hour 50 mcg/hr transdermal... 7 fentanyl patch 72 hour 75 mcg/hr transdermal... 7 FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG... 1 FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 20 MG... 1 FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 40 MG... 1 17

FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 80 MG... 1 FETZIMA TITRATION CAPSULE ER 24 HOUR THERAPY PACK 20 & 40 MG... 1 G GEODON SOLUTION RECONSTITUTED 20 MG INTRAMUSCULAR... 4 I INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML INTRAMUSCULAR... 4 INVEGA SUSTENNA SUSPENSION 156 MG/ML INTRAMUSCULAR... 4 INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INTRAMUSCULAR... 4 INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INTRAMUSCULAR... 4 INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INTRAMUSCULAR... 4 K KINERET SOLUTION PREFILLED SYRINGE 100 MG/0.67ML... 8 M MARPLAN TABLET 10 MG... 1 N NULOJIX SOLUTION RECONSTITUTED 250 MG INTRAVENOUS... 9 O OPSUMIT TABLET 10 MG... 11 ORENCIA CLICKJECT SOLUTION AUTO-INJECTOR 125 MG/ML... 8 ORENCIA SOLUTION PREFILLED SYRINGE 125 MG/ML... 8 ORENCIA SOLUTION RECONSTITUTED 250 MG INTRAVENOUS... 8 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 10 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 15 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 20 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 30 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 40 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 60 MG... 12 OXYCODONE HCL ER TABLET ER 12 HOUR ABUSE-DETERRENT 80 MG... 12 P paliperidone er tablet extended release 24 hour 1.5 mg oral... 4 paliperidone er tablet extended release 24 hour 3 mg oral... 4 paliperidone er tablet extended release 24 hour 6 mg oral... 4 paliperidone er tablet extended release 24 hour 9 mg oral... 4 PAXIL SUSPENSION 10 MG/5ML... 1 PEXEVA TABLET 10 MG... 1 PEXEVA TABLET 20 MG... 1 PEXEVA TABLET 30 MG... 1 PEXEVA TABLET 40 MG... 1 PROLIA SOLUTION 60 MG/ML... 13 R RELISTOR SOLUTION 12 MG/0.6ML... 14 RELISTOR SOLUTION 12 MG/0.6ML (0.6ML SYRINGE)... 14 RELISTOR SOLUTION 8 MG/0.4ML... 14 RELISTOR TABLET 150 MG... 14 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG INTRAMUSCULAR... 4 18

RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG INTRAMUSCULAR... 4 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG INTRAMUSCULAR... 4 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG INTRAMUSCULAR... 4 S SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL... 4 SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL... 4 SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL... 4 SIMPONI ARIA SOLUTION 50 MG/4ML INTRAVENOUS... 8 SIMPONI SOLUTION AUTO-INJECTOR 100 MG/ML... 8 SIMPONI SOLUTION AUTO-INJECTOR 50 MG/0.5ML... 8 SIMPONI SOLUTION PREFILLED SYRINGE 100 MG/ML... 8 SIMPONI SOLUTION PREFILLED SYRINGE 50 MG/0.5ML... 8 STELARA SOLUTION PREFILLED SYRINGE 45 MG/0.5ML... 8 STELARA SOLUTION PREFILLED SYRINGE 90 MG/ML... 8 T tacrolimus ointment 0.03 % external... 3 tacrolimus ointment 0.1 % external... 3 TRINTELLIX TABLET 10 MG... 1 TRINTELLIX TABLET 20 MG... 1 TRINTELLIX TABLET 5 MG... 1 U UCERIS FOAM 2 MG/ACT RECTAL... 15 UCERIS TABLET EXTENDED RELEASE 24 HOUR 9 MG... 15 V VERSACLOZ SUSPENSION 50 MG/ML... 4 VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG... 4 X XELJANZ TABLET 5 MG... 8 XTANDI CAPSULE 40 MG... 16 Z ZORTRESS TABLET 0.25 MG... 9 ZORTRESS TABLET 0.5 MG... 9 ZORTRESS TABLET 0.75 MG... 9 19